Free Trial

Gilead Sciences (GILD) SEC Filings & 10K Form

$84.59
+0.42 (+0.50%)
(As of 10/4/2024 ET)

Recent Gilead Sciences SEC Filings

DateFilerForm TypeView
10/02/2024
3:58 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
6:07 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:08 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:43 PM
Gilead Sciences (Subject)
Mercier Johanna (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:45 PM
Gilead Sciences (Subject)
Parsey Merdad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
6:30 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:33 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:38 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:41 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:20 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:23 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
2:23 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
1:23 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
4:17 PM
Gilead Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2024
4:28 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
8:01 AM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
7:06 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
7:31 PM
ASSEMBLY BIOSCIENCES, INC. (Issuer)
Gilead Sciences (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
7:35 PM
ASSEMBLY BIOSCIENCES, INC. (Subject)
Gilead Sciences (Filed by)
Form SC 13D/A
06/11/2024
6:12 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:15 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:18 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:20 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:23 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:25 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:57 PM
BARTON JACQUELINE K (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:16 PM
Gilead Sciences (Issuer)
MANWANI HARISH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:23 PM
Gilead Sciences (Issuer)
WELTERS ANTHONY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:26 PM
Gilead Sciences (Issuer)
Rodriguez Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:30 PM
Gilead Sciences (Issuer)
LOVE TED W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:08 PM
Bluestone Jeffrey (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
8:29 PM
GALAPAGOS NV (Subject)
Gilead Sciences (Filed by)
Form SC 13D/A
04/19/2024
3:31 PM
Gilead Sciences (Reporting)
LEAP THERAPEUTICS, INC. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/19/2024
3:31 PM
Gilead Sciences (Filed by)
LEAP THERAPEUTICS, INC. (Subject)
Form SC 13G
04/05/2024
3:31 PM
Gilead Sciences (Filed by)
Xilio Therapeutics, Inc. (Subject)
Form SC 13G
04/03/2024
5:48 PM
Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2024
5:50 PM
Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:38 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
4:19 PM
Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:07 PM
Gilead Sciences (Filer)
Form DEF 14A
03/28/2024
3:07 PM
Gilead Sciences (Filer)
Form DEFA14A
Sell NVDA Now? (Ad)

Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.

Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA).
03/22/2024
8:21 AM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
6:50 AM
CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC TO-T/A
03/20/2024
3:12 PM
CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC TO-T/A
03/15/2024
3:11 PM
CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC TO-T/A
03/12/2024
3:19 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:11 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:14 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:59 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:03 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:34 AM
CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC TO-T/A
02/29/2024
5:35 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:49 PM
Gilead Sciences (Subject)
Parsey Merdad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
3:38 PM
Gilead Sciences (Subject)
Parsey Merdad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2024
5:09 AM
CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC TO-T
02/13/2024
4:48 PM
Gilead Sciences (Reporting)
Kyverna Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
7:37 AM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
7:39 AM
CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC TO-C
02/09/2024
5:21 PM
Capital World Investors (Filed by)
Gilead Sciences (Subject)
Form SC 13G/A
02/07/2024
4:35 PM
Gilead Sciences (Reporting)
Kyverna Therapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2024
5:01 PM
Gilead Sciences (Issuer)
LOVE TED W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:20 PM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
1:42 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
1:34 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
1:19 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
1:11 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
12:40 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:58 PM
Arcus Biosciences, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC 13D/A
01/31/2024
4:00 PM
Arcus Biosciences, Inc. (Issuer)
Gilead Sciences (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
Gilead Sciences (Subject)
Form SC 13G/A
01/17/2024
5:01 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
3:32 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:35 PM
Gilead Sciences (Subject)
Mercier Johanna (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/29/2023
3:36 PM
Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:06 PM
Arcellx, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC 13G/A
12/28/2023
4:09 PM
Arcellx, Inc. (Issuer)
Gilead Sciences (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/22/2023
3:07 PM
Gilead Sciences (Reporting)
HOOKIPA Pharma Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/11/2023
6:00 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
6:04 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
6:08 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
6:10 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
6:15 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
5:21 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
4:18 PM
Gilead Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/26/2023
4:56 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2023
6:15 PM
ASSEMBLY BIOSCIENCES, INC. (Issuer)
Gilead Sciences (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/25/2023
4:18 PM
ASSEMBLY BIOSCIENCES, INC. (Subject)
Gilead Sciences (Filed by)
Form SC 13D
10/19/2023
2:33 PM
Gilead Sciences (Filed by)
Ikena Oncology, Inc. (Subject)
Form SC 13G
10/18/2023
3:31 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2023
3:18 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GILD) was last updated on 10/6/2024 by MarketBeat.com Staff
From Our Partners